Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Sodium valproate information hub
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
Welsh Government statements
Welsh Government statements
23/02/2022
Welsh Government written statement: Access to cystic fibrosis triple therapy
25/02/2020
Welsh Government written statement: Access agreement for the cystic fibrosis medicines Orkambi and Symkevi
24/02/2020
Welsh Government written statement: All Wales study to provide Truvada to all those who would benefit from the preventative treatment
25/02/2020
Welsh Government written statement: Availability of ivacaftor (Kalydeco) within NHS Wales for the treatment of cystic fibrosis
Follow AWTTC:
